FLSM
STTK icon

Frazier Life Sciences Management’s Shattuck Labs STTK Stock Holding History

Frazier Life Sciences Management’s Portfolio STTK Stock Details STTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$26M Buy
+3,750,000
New +$23.4M 0.57% 30

Other funds holding STTK

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $580M AUM 29.81% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
NCM
NEXTBio Capital Management Menlo Park, California $217M AUM
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Frazier Life Sciences Management's STTK Position: Q2 2026 in Review

Frazier Life Sciences Management opened a new position in Shattuck Labs (STTK) in Q2 2026: 3,750,000 shares worth $26M. The stake represents 0.57% of the portfolio and ranks #30 among its holdings.

99 funds tracked by Wall St. Rank hold STTK as of Q2 2026.

  • Frazier Life Sciences Management held 3,750,000 shares of Shattuck Labs worth $26M as of Q2 2026.
  • Shattuck Labs was a new Frazier Life Sciences Management position in Q2 2026.
  • Shattuck Labs made up 0.57% of Frazier Life Sciences Management's portfolio in Q2 2026, its #30 holding.
  • 99 funds tracked by Wall St. Rank held Shattuck Labs as of Q2 2026.

Based on Frazier Life Sciences Management's 13F filing for Q2 2026, filed 14 Aug 2026.